Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow TransplantationJeffery J. Auletta, Kenneth R. Cooke, Patiwet Wuttisarnwattana et al.|Stem Cells|2014Cited by 90
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosisPeter J. Darlington, Amit Bar‐Or, Marie‐Noëlle Boivin et al.|Annals of Neurology|2010Cited by 80
Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future DirectionsJeffery J. Auletta, Wouter Van’t Hof, Kenneth R. Cooke et al.|Transplantation and Cellular Therapy|2009Cited by 46
Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive PotentialJeffery J. Auletta, Luis A. Solchaga, Elizabeth Zale et al.|Stem Cells International|2011Cited by 42
Human Mesenchymal Stem Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia in Murine Allogeneic Bone Marrow TransplantationJeffery J. Auletta, Kenneth R. Cooke, Saada Eid et al.|Blood|2011Cited by 1